Interventional treatments for hepatocellular carcinoma

Hepatobiliary and Pancreatic Diseases International

Volumn 5, Issue 4, 2006, Pages 495-500

  Guan, Yong Song ^a   Liu, Yuan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Carcinoma; Hepatocellular; Local ablative therapy; Transarterial chemoembolization

Indexed keywords

ACETIC ACID; ADVEXIN; ALCOHOL;

CANCER SURVIVAL; CHEMOEMBOLIZATION; CRYOTHERAPY; GENE THERAPY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INTERVENTION STUDY; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LOW LEVEL LASER THERAPY; MEDLINE; MICROWAVE THERAPY; PROGNOSIS; RADIOFREQUENCY ABLATION; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW; TUMOR NECROSIS;

ACETIC ACID; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; CRYOSURGERY; ETHANOL; HUMANS; HYPERTHERMIA, INDUCED; LIVER NEOPLASMS; MICROWAVES; ULTRASONIC THERAPY;

EID: 33751210578     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Kew MC. Epidemiology of hepatocellular carcinoma. Toxicology 2002;181-182:35-38.
2. Liver Cancer Study Group of Japan. Primary liver cancers in Japan. Cancer 1980;45:2663-2669.
3. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995;221:291-298.
4. Alsowmely AM, Hodgson HJ. Non-surgical treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 2002;16:1-15.
5. Otto G, Heuschen U, Hofman WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma. Ann Surg 1998;227:424-432.
6. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-1440.
7. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003;362:1907-1917.
8. Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. Am J Roentgenol 1993;160:1023-1028.
9. Sala M, Llovet JM, Vilana R, Bianchi L, Sole M, Ayuso C, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004;40:1352-1360.
10. Livraghi T, Giorigo A, Marin G, Salmi A, de Sio I, Bolondi L, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-108.
11. Kume A, Nimura Y, Kamiya J, Nagino M. Kito Y. Percutaneous ethanol injection via an artificially induced right hydrothorax for hepatocellular carcinoma in the hepatic dome. Cardiovasc Intervent Radiol 2003;26:543-549.
12. Hasegawa S, Yamasaki N, Hiwaki T, Sako K, Komorizono Y, Baba Y, et al. Factors that predict intrahepatic recurrence of hepatocellular carcinoma in 81 patients initially treated by percutaneous ethanol injection. Cancer 1999;86:1682-1690.
13. Livraghi T. Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2003;10:67-76.
14. Ebara M, Okabe S, Kita K, Sugiura N, Fukuda H, Yoshikawa M, et al. Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation. J Hepatol 2005;43:458-464.
15. Khan KN, Yatsuhashi H, Yamasaki, Yamasaki M, Inoue O, Koga M, et al. Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection. J Hepatol 2000;32:269-278.
16. Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, Hu RH, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 2005;242:36-42.
17. Daniele B, De Sio I, Izzo F, Capuano G, Andreana A, Mazzanti R, et al. Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control study. J Clin Gastroenterol 2003;36:63-67.
18. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rucca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001;11:914-921.
19. Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer 2003;97:3027-3035.
20. Amersi FF, McElrath-Garza A, Ahmad A, Zogakis T, Allegra DP, Krasne R, et al. Long-term survival after radiofrequency ablation of complex unresectable live tumors. Arch Surg 2006;141:581-587.
21. Lencioni R, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, et al. Small hepatocellular carcinoma in cirrhosis: randomized controlled trial of radiofrequency termal ablation versus percutaneous ethanol injection. Radiology 2003;228:235-240.
22. Rossi S, Garbagnati F, Lencioni R, Allgaier HP, Marchianò A, Fornari F, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 2000;217:119-126.
23. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005;54:1151-1156.
24. Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003;38:977-981.
25. Gillams AR. Image guided tumour ablation. Cancer Imaging 2005;5:103-109.
26. Ohnishi K, Ohyama N, Ito S, Fujiwara K. Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. Radiology 1994;193:747-752.
27. Ohnishi K. Comparison of percutaneous acetic acid injection and percutansous ethanol injection for small hepatocellular carcinoma. Hepatogastroenterology 1998;45 (Suppl 3):1254-1258.
28. Huo TI, Huang YH, Wu JC, Chiang JH, Lee PC, Chang FY, et al. Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study. Ann Oncol 2003;14:1648-1653.
29. Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994;74:817-825.
30. Dong BW, Liang P, Yu XL, Zeng XQ, Wang PJ, Su L, et al. Sonographically guided microwave coagulation treatment of liver cancer: an experimental and clinical study. Am J Roentgenol 1998;171:449-454.
31. Dong BW, Liang P, Yu XL, Li S, Yu DJ, Cheng ZG, et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. Am J Roentgenol 2003;180:1547-1555.
32. Liang P, Dong BW, Xu XL, Yu D, Cheng Z, Su L, et al. Computer-aided dynamic simulation of microwave-induced thermal distribution in coagulation of liver cancer. IEEE Trans Biomed Eng 2001;48:821-829.
33. Vogl TJ, Straub R, Eichler K, Woitaschek D, Mack MG. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2520 lesions). Radiology 2002;225:367-377.
34. Vogl TJ, Mack MG, Roggan A, Straub R, Eichler KC, Muller PK, et al. Internally cooled power laser for MR-guided interstitial laser-induced thermotherapy of liver lesions: initial clinical results. Radiology 1998;209:381-385.
35. Pacella CM, Bizzarri G, Cecconi P, Caspani B, Magnolfi F, Bianchini A, et al. Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 2001;219:669-678.
36. Guo Z, Xin WG, Liu F, Yu HP, Li BG, Guo XY, et al. Clinical application of Argon-helium cryotherapy system in the treatment of hepatocellular carcinoma. Chin J Radiol 2005;39:198-203.
37. Wu F, Wang Z, Chen W. Pathological study of extracorporeally ablated hepatocellular carcinoma with high-intensity focused ultrasound. Zhonghua Zhong Liu Za Zhi 2001;23:237-239.
38. Wu F, Wang ZB, Chen WZ, Zou JZ, Bai J, Zhu H, et al. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 2005;235:659-667.
39. Dyon D, Mouzon A, Jourde AN, Regensberg C, Frileux C. Hepatic, arterial embolization in patients with malignant liver tumours. Ann Radiol 1974;17:593-603.
40. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-442.
41. Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987;163:345-351.
42. Sumie S, Yamashita F, Ando E, Tanaka M, Yano Y, Fukumori K, et al. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization. AJR Am J Roentgenol 2003;181:1327-1334.
43. Lin SC, Shih SC, Kao CR, Chou SY. Transcatheter arterial embolization treatment in patients with hepatocellular carcinoma and risk of pulmonary metastasis. World J Gastroenterol 2003;9:1208-1211.
44. No authors listed. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Group d'Etude et de Traitment du Carcinome Hepatocellulaire. N Engl J Med 1995;332: 1256-1261.
45. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002;359:1734-1739.
46. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164-1171.
47. Uraki J, Yamakado K, Nakatsuka A, Takeda K. Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors. Eur J Radiol 2004;51:12-18.
48. Boucher E, Corbinais S, Rolland Y, Bourguet P, Guyader D, Boudjema K, et al. Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma. Hepatology 2003;38:1237-1241.
49. Rand T, Loewe C, Schoder M, Schmook MT, Peck-Radosavljevic M, Kettenbach J, et al. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate. Cardiovasc Intervent Radiol 2005;28:313-318.
50. Furuse J, Ishii H, Satake M, Onaya H, Nose H, Mikami S, et al. Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma. Am J Clin Oncol 2003;26:159-164.
51. Gunji T, Kawauchi N, Akahane M, Watanabe K, Kanamori H, Ohnishi S. Treatment of unresectable hepatocellular carcinoma less than 2 centimeters by transcatheter arterial chemoembolization with autologous blood clot. J Clin Gastroenterol 2003;36:347-351.
52. Okusaka T, Okada S, Nakanishi T, Fujiyama S, Kubo Y. Phase II trial of intra-arterial chemotherapy using a novel lipophilic platinum derivative (SM-11355) in patients with hepatocellular carcinoma. Invest New Drugs 2004;22: 169-176.
53. Guan YS, Liu Y, Zhou XP, Li X, He Q, Sun L. p53 gene (Gendicine) and embolisation overcame recurrent hepatocellular carcinoma. Gut 2005;54:1318-1319.